Susana de Almeida, completed her LSc degree in Aquatic Sciences (Marine Biology) in 1997. In 2009 she was conferred a MSc degree in Medicine and Molecular Oncology at the Faculty of Medicine, University of Porto (FMUP), Portugal. Presently, she is a PhD student at Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal under the supervision of Dr. Pedro F. Oliveira and co-supervision of Prof. Mário Sousa and Prof. Alberto Barros. Her research interests are in Aging, its impact on fertility, and in the male reproductive biology research field.
“Envolvimento das mutações do gene da Hemocromatose (HFE) na Hemofilia”. Investigador responsável: Eugénia Cruz. Instituições: IBMC, HGSA, Porto (Serviço de Hematologia Clínica). Financiamento: Forum Hematológico do Norte (FHN)
“Genetics of Alzheimer Disease”. Investigador Principal: Graça Porto. Responsável Clínica: Ana Paula Correia., Instituições: IBMC, Hospital de Magalhães Lemos ; Financiamento: Lundbeck Portugal Lda.“HFE mutations and HLA polymorphisms: a population based study”. Investigador Investigador responsável: Graça Porto. Instituições: IBMC, HGSA, Porto (Serviço de Hematologia Clínica) Financiamento: FCT - POCTI/32986/MGI/2000:
Fellowships and Prizes:
2018 – FEBS Congress Grant to attend and present a poster at the 43rd FEBS Congress, 7-12 July 2018, Prague, Czech Republic.
2015 - 4-year PhD fellowship from the Portuguese Foundation for Science and Technology (FCT).
Proceedings in Peer-reviewed Journals:
Publications:
8. Correia AP, Pinto JP, Dias V, Mascarenhas C, Almeida S, Porto G (2009) CAT53 and HFE alleles in Alzheimer's disease: a putative protective role of the C282Y HFE mutation. Neurosci Lett. 457(3):129-32.
7. Beirão I, Almeida S, Swinkels D, Costa PM, Moreira L, Fonseca I, Freitas C, Cabrita A, Porto G (2008) Low serum levels of prohepcidin, but not hepcidin-25, are related to anemia in familial amyloidosis TTR V30M. Blood Cells Mol Dis. 41:175-82.
6. Vieira J, Cardoso CS, PintoJ, Patil K, Brazdil P, Cruz E, Mascarenhas C, Lacerda R, Gartner A, Almeida S, Alves H and Porto G (2007) A putative gene located at the MHC-class I region around the D6S105 marker contributes to the setting of CD8+ T lymphocyte numbers in humans. Int J Immunogenet; 34:359-367
5. Cardoso CS, Araújo H, Cruz E, Afonso A, Mascarenhas C, Almeida S, Moutinho J, Lopes C, Medeiros R (2006) Haemochromatosis gene (HFE) mutations in viral-associated neoplasia: Linkage to cervical cancer. BBRC; 341: 232-238
4. Cruz E, Vieira E, Almeida S, Lacerda R, Gartner A, Cardoso CS, Alves H and Porto G. (2006) A study of 82 extended HLA haplotypes in HFE-C282Y homozygous hemochromatosis subjects: relationship to the genetic control of CD8+ T-lymphocyte numbers and severity of iron overload. BMC Medical Genetics 7:16
3. Cruz E, Melo G, Lacerda R, Almeida S, Porto G. (2006) The CD8+ T-Lymphocyte profile as a modifier of iron overload in HFE hemochromtosis: An update of clinical and immunological data from 70 C282Y Homozygous subjects. BloodCells, Molecules &Diseases 37 (2006) 33-39.
2. Porto G, Roetto A, Daraio F, Pinto JP, Almeida S, Bacelar C, Nemeth E, Ganz T and Camaschella C. (2005) A Portuguese patient homozygous for the -25G>A mutation of the HAMP promoter shows evidence of steady-state Transcription but fails to up-regulate hepcidin levels by iron. Blood, volume 106:2922-3.
1. Cruz E, Vieira J, Gonçalves R, Alves H, Almeida S, Rodrigues P, Lacerda R, Porto G (2004) Involvement of the major histocompatibility complex region in the genetic Regulation of circulation CD8 T – Cell numbers in humans.”Tissue Antigens. 64(1):25 – 34